/Research

IC & Pain – Have you been denied pain treatment?

A New ICN Survey (March 2017) The pain of interstitial cystitis has been rated equivalent to cancer pain using the McGill pain scale in various research studies. Yet, despite what can be very intense pain, many patients have been struggling to receive pain treatment or denied pain medication. With the 2016 release of the [...]

By | 2017-03-31T12:17:11+00:00 March 9th, 2017|Interstitial Cystitis Network Blog, Research|Comments Off on IC & Pain – Have you been denied pain treatment?

Is IC an Autoimmune Condition?

Behind the redness, swelling, heat and pain of any infection or injury, a biological war is occurring. Injured cells release chemicals that alert our immune system that something is wrong. One of these chemicals, chemokines, attract and direct white blood cells (i.e. macrophages, lymphocytes) to the injured area where they swarm and kill invading bacteria [...]

By | 2017-02-27T21:33:48+00:00 February 27th, 2017|Interstitial Cystitis Network Blog, Research|Comments Off on Is IC an Autoimmune Condition?

Three Treatments For Hunner’s Lesion Show Promise – LiRIS, Triamcinolone, Cyclosporine

LiRIS Found Safe & Effective In First Formal Hunner’s Lesion Study When the first round of LiRIS studies were conducted several years ago, researchers were stunned to see that some Hunner’s lesions healed after just a two week treatment with this innovative medical device devel- oped at MIT. LiRIS was originally intended as a pain [...]

By | 2017-02-28T16:44:14+00:00 February 27th, 2017|Research|Comments Off on Three Treatments For Hunner’s Lesion Show Promise – LiRIS, Triamcinolone, Cyclosporine

Q&A With Dr. Eliot Lander on Stem Cell Therapy & Pentosan Liposome Therapy

Dr. Eliot Lander On Stem Cell Therapy For IC #1 - As the only researcher in the world studying the use of stem cells in the treatment of interstitial cystitis, you have opened a potential new line of therapy. Is your most recent round of data encouraging?? I strongly believe that adult mesenchymal stem cells will [...]

By | 2017-02-27T21:07:36+00:00 February 27th, 2017|Research|Comments Off on Q&A With Dr. Eliot Lander on Stem Cell Therapy & Pentosan Liposome Therapy

CUA IC/BPS Guidelines Finally Adopted – Canadian Patients Get Much Needed Guidance

CUA IC/BPS Guidelines Adopted Why have so many interstitial cystitis patients in Canada come to the USA for care? Despite the glowing reviews about universal health care, there is a sad IC truth behind the scenes north of the border. There is no national IC organization to advocate on their behalf. Only a handful of physicians in [...]

By | 2017-01-20T16:34:08+00:00 December 7th, 2016|Awareness, Diagnosis, ICN Announcements, Industry News, Interstitial Cystitis Network Blog, News, Research, Treatments|Comments Off on CUA IC/BPS Guidelines Finally Adopted – Canadian Patients Get Much Needed Guidance

Substantial Revision and Removal Rate for Interstim

Neuromodulation uses a mild electrical impulse on various nerves to help maintain appropriate nerve function in the bladder. Two different forms of neuromodulation are available: post-tibial nerve stimulation (Urgent PC® by Congentix Medical) and sacral or pudendal nerve stimulation (Interstim® by Medtronic). Both procedures are FDA and Medicare approved for urinary frequency, urgency, incontinence and overactive [...]

By | 2017-01-18T12:01:13+00:00 October 23rd, 2016|Interstitial Cystitis Network Blog, Latest Research, Research|Comments Off on Substantial Revision and Removal Rate for Interstim

A New Chronic Pelvic Pain Terminology Guide Adds Clarity For IC

Earlier this year, the International Continence Society released new terminology standards to aid in the diagnosis of ALL chronic pelvic pain disorders, including those that affect the bladder(1). This is a powerful document that will help physicians and patients identify and classify potential sources of their pelvic pain. Consider the plight of a young patient with [...]

By | 2017-01-18T12:01:15+00:00 October 19th, 2016|Conference Reports, Interstitial Cystitis Network Blog, Latest Research, Research|Comments Off on A New Chronic Pelvic Pain Terminology Guide Adds Clarity For IC

New IC Treatments Currently in the IC Pipeline

New, Promising Treatments - AF 219, LiRIS, AQX-1125, GM-0111, LP-08 Patients constantly ask "Is there anything new?" Yes, Virginia, IC research is alive and well with teams from around the world exploring new treatments. Here's our review of the most promising projects in the IC Pipeline! Afferent Pharmaceuticals AF-219 Afferent Pharmaceuticals is developing a potential new [...]

By | 2016-10-07T17:37:04+00:00 October 7th, 2016|Interstitial Cystitis Network Blog, Latest Research, Research|Comments Off on New IC Treatments Currently in the IC Pipeline

IC Patient Develops Aortic Aneurysm After Using Cipro

New FDA Warning About Fluoroquinolone Antibiotics - When IC patient Naomi* was prescribed Cipro for a bladder infection several years ago, she had no idea that it would lead to a life threatening aortic aneurysm. She, and others, found both both answers and outrage in an FDA safety alert released in May which required a [...]

By | 2017-01-18T12:01:28+00:00 July 18th, 2016|Interstitial Cystitis Network Blog, Research|Comments Off on IC Patient Develops Aortic Aneurysm After Using Cipro

The DIPP Mystery – Why are IC patients deficient in some good bacteria?

Researchers have discovered that IC patients have significantly different levels and types of bacteria in our digestive tract (bowel) rather than our urinary tract (kidney, bladder). These distinct deficiencies (known as DIPP) hint that the lack of beneficial bacteria as well as an overabundance of pathogenic bacteria play a role in the cause and intensity of bladder and [...]

By | 2017-01-18T12:01:30+00:00 June 16th, 2016|Interstitial Cystitis Network Blog, Research|Comments Off on The DIPP Mystery – Why are IC patients deficient in some good bacteria?